Stockscreener 앱 받기
20.52
3.21%
-0.68
10 X Genomics Inc 주식(TXG)의 최신 뉴스
Sumitomo Mitsui Trust Group Inc. Sells 636,744 Shares of 10x Genomics $TXG - MarketBeat
Aug Weekly: Whats the fair value of AN2 Therapeutics Inc stockWeekly Investment Summary & Technical Pattern Alert System - baoquankhu1.vn
Wall Street Recap: What is INTA s revenue forecastTrade Performance Summary & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Insider Trends: Will 10x Genomics Inc outperform its industry peersJuly 2025 Review & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Weak Instrument Sales And No 2026 Outlook Could Be A Game Changer For 10x Genomics (TXG) - Yahoo Finance
10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at Valuation Challenges Amidst Sector Potential - DirectorsTalk Interviews
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling - BioSpace
Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and 10x Genomics (TXG) - The Globe and Mail
Why 10x Genomics (TXG) Shares Are Falling Today - Finviz
10x Genomics (NASDAQ:TXG) Shares Down 8.5%What's Next? - MarketBeat
Cancer Research Institute Launches Transformative AI-Driven Immu - GuruFocus
10x Genomics partners with Dana-Farber to research cancer treatment responses - Investing.com
10x Genomics partners with Brigham & Women’s for autoimmune research - Investing.com
10x Genomics partners with Brigham & Women’s for autoimmune research By Investing.com - Investing.com Canada
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease - Chartmill
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology - PR Newswire
10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus
10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha
10x Genomics (TXG) Achieves Remarkable Progress Despite Economic Challenges - GuruFocus
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results - The Malaysian Reserve
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results | TXG Stock News - Longbridge
Revenues Not Telling The Story For 10x Genomics, Inc. (NASDAQ:TXG) After Shares Rise 32% - 富途牛牛
Cathie Wood's ARK buys Qualcomm and 10X Genomics stock - MSN
Aug Swings: Is 10x Genomics Inc. stock oversold or undervalued2025 Risk Factors & Expert Approved Momentum Trade Ideas - Улправда
Will 10x Genomics Inc. stock split attract more investorsJuly 2025 Highlights & Verified Swing Trading Watchlist - Улправда
10x Genomics (NASDAQ:TXG) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Published on: 2026-01-10 18:33:58 - moha.gov.vn
10x Genomics (NASDAQ:TXG) Reaches New 12-Month HighShould You Buy? - MarketBeat
10X Genomics stock hits 52-week high at 20.36 USD - Investing.com
10X Genomics stock hits 52-week high at 20.36 USD By Investing.com - Investing.com India
Is 10x Genomics Inc. stock a safe haven asset2025 Market Sentiment & Safe Capital Allocation Plans - ulpravda.ru
Can 10x Genomics Inc. (1KJ) stock sustain breakout momentumWeekly Gains Summary & Reliable Entry Point Alerts - Улправда
What technical charts say about 10x Genomics Inc. stockJuly 2025 Catalysts & Accurate Intraday Trade Tips - ulpravda.ru
Is 10x Genomics Inc. stock oversold or undervalued2025 Risk Factors & Expert Approved Momentum Trade Ideas - Улправда
Gains Recap: Why 10x Genomics Inc. stock is favored by top institutionsJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - Улправда
Risk Check: How 10x Genomics Inc. stock benefits from strong dollar2025 Market Trends & Accurate Intraday Trading Signals - ulpravda.ru
Is 10x Genomics Inc. stock safe for conservative investorsValue Stock Picks & Free Wealth Planning Blueprints - Улправда
10x Genomics (TXG) Sees Target Price Increase in Latest Analyst Rating | TXG Stock News - GuruFocus
Why 10x Genomics Inc. stock could outperform in 2025Dividend Aristocrats List & Small Capital Trading Growth - ulpravda.ru
10x Genomics (NASDAQ:TXG) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma
CareDx and 10x Genomics partner on transplant rejection research - Investing.com
CareDx, Inc. and 10x Genomics to Launch ImmuneScapeA Multiomics Research Platform to Decode Transplant Rejection and Drug Response - marketscreener.com
Page not foundFactor Thisâ„¢ - FinancialContent
10x Genomics (TXG) Stock Is Up, What You Need To Know - Finviz
10x Genomics (TXG) Gains as Analysts Raise Price Targets in Early 2026News and Statistics - IndexBox
Financial Consulate Inc. Acquires New Holdings in 10x Genomics $TXG - MarketBeat
Weekly Earnings: Is 10x Genomics Inc 1KJ stock a top pick for value investorsWeekly Investment Report & Low Drawdown Trading Strategies - moha.gov.vn
S P Trends: How dovish Fed policy supports 10x Genomics Inc 1KJ stockMarket Sentiment Review & Weekly Watchlist of Top Performers - moha.gov.vn
10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Market with a 7.47% Potential Upside - DirectorsTalk Interviews
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GuruFocus
10x Genomics' Products Are Well-Received, But US Spending Weakness Stifles Growth (NASDAQ:TXG) - Seeking Alpha
Osaic Holdings Inc. Has $1.89 Million Stock Position in 10x Genomics $TXG - MarketBeat
Assenagon Asset Management S.A. Sells 1,696,984 Shares of 10x Genomics $TXG - MarketBeat
2.26%
2.88%
자본화:
|
볼륨(24시간):